The Opportunity Scan
Know where AI will pay off — before you spend a year finding out.
The Opportunity Scan is a fixed-scope, fixed-fee assessment: in 3–4 weeks you get a scored portfolio of your highest-value AI and automation opportunities, a light business case for the top candidates, and a recommended first move with KPIs.
Why a Scan
Evidence instead of opinion
Most organizations don’t lack AI ideas — they lack a defensible way to choose among them. Pilots multiply, none scale, and clinical teams grow rightly skeptical. The Scan replaces opinion with evidence: a structured pass through your actual workflows, constraints and data readiness, scored consistently, so leadership can commit to the two or three initiatives that will genuinely move the organization.
Track record
Built on delivery, not theory
The Scan's method comes from 20+ years of hands-on HealthTech delivery, not a framework adapted from another industry.
National ED digitization
Emergency-department digitization across 20+ hospitals.
National digital-health assessment
A national health-information-exchange assessment for the Government of The Bahamas.
Geriatric Network Digital Transformation
AI and automation across Israel's largest geriatric and senior-care network — rehabilitation hospitals, sheltered housing and home care.
Live AI & automation workflows
AI and automation workflows running today in live hospital operations.
Scope
What goes in, what comes out
What goes in
- 6–10 leadership and clinical interviews.
- A workflow and pain-point pass on 2–3 focus areas.Typical focus areas: referrals, clinical documentation, scheduling, patient communication, prior authorization, back-office processing — or the operational bottleneck you already know about.
- A technology and data readiness check.
What you receive
- The Transformation Opportunity Portfolio
- A scored heatmap of identified opportunities
- The top 2–3 initiatives with a light business case
- Risks, dependencies and readiness requirements
- Recommended KPIs and accountable owners
- A proposed 90-day first sprint
- An executive decision session
Scoring
The Aprinove Opportunity Score
Every opportunity is scored on four dimensions: value × feasibility × risk × readiness. The same scoring model is applied to every opportunity, so your options are ranked consistently against one another rather than argued case by case.
The portfolio is delivered as a scored heatmap across functional areas, with each opportunity carrying its value, feasibility, risk and readiness rating, dependencies and a recommended sequence. We walk through the format with you on the fit call.
Timeline
The four weeks
- 01
Week 1 — Listen
Leadership and clinical interviews; alignment on the 2–3 focus areas.
- 02
Week 2 — Look
Workflow walk-throughs and pain-point mapping in the focus areas; technology and data readiness check.
- 03
Week 3 — Score
The full opportunity portfolio is built and scored; light business cases for the leaders.
- 04
Week 4 — Decide
Executive readout: the portfolio, the top initiatives, and a recommended first sprint your team can start immediately.
Best fit
The Opportunity Scan is designed for healthcare organizations that:
- Have multiple AI or automation ideas but no defensible prioritization method
- Have pilots that are struggling to scale
- Face a visible operational bottleneck or administrative burden
- Need to demonstrate measurable value from AI investment
- Want an independent, technology-neutral assessment before selecting a vendor
Not the right fit
The Scan may not be the right starting point if:
- The organization has not identified an executive sponsor
- The objective is primarily to select a predetermined product
- There is no access to operational or clinical stakeholders
- Leadership is seeking a general AI presentation rather than an investment decision
Who sponsors it
The Scan is typically sponsored by the COO or CMIO — the owners of operational and clinical-workflow burden — with the CIO or CDO as technical counterpart. It needs no system access beyond read-level familiarity, and around 10–12 hours of your people’s time in total.
What it is not
It is not an AI strategy deck, a vendor evaluation, or a sales channel for any product. Aprinove is technology-neutral: if the right answer in an area is “don’t use AI here,” that is what the portfolio will say.
Fixed scope. Fixed duration. Fixed fee.
The fee is confirmed after a 30-minute fit call and depends on organizational scope and the number of focus areas. The engagement is designed to be a straightforward decision compared with the cost and delay of an unsuccessful pilot.
FAQ
Questions executives ask
Do you need access to patient data?
No. The Scan works from interviews, workflow observation and architecture-level documentation. No patient-identifiable data is required or processed. If a specific question can only be answered with operational data, we agree an aggregated or de-identified extract with your information-governance team first.
Can you work with existing pilots?
Yes — and it is often the best moment to run a Scan. The portfolio places existing pilots alongside unexplored opportunities on one scored map, which is usually when the real priorities, and the pilots worth stopping, become visible.
Who participates from our organization?
An executive sponsor (typically the COO or CMIO), a technical counterpart (CIO, CDO or equivalent), and 6–10 interviewees drawn from clinical, operational and administrative teams in the focus areas.
How much internal time is required?
Around 10–12 hours in total across your organization: interviews of 45–60 minutes each, two or three workflow walk-throughs, and the executive readout session. We work around clinical schedules.
Who performs the work?
Amir Gilboa personally leads every Scan — the interviews, the analysis and the readout. Specialist input is added only where the scope requires it, and always under his accountability.
What happens after the Scan?
Whatever you decide. Some clients run the recommended first sprint with us; some take the portfolio and execute internally or with existing partners. The deliverable is written to be actionable either way — no dependency on Aprinove is designed in.
Can the Scan end with a recommendation not to proceed?
Yes. Aprinove is technology-neutral, and if the evidence shows that an area should not be automated yet — or that readiness work must come first — that is what the portfolio will say. A clear “not now” is a valid and valuable outcome.
Can Aprinove work with US, UK and European procurement requirements?
Yes. Vendor onboarding documentation, security questionnaires, data-protection agreements and invoicing arrangements are handled per engagement and per jurisdiction. See the Trust, Security & Procurement page for our general posture.